James R Spivey, MD

Emory Clinic

Vice Chair for Clinical Affairs, Department of Medicine;Medical Director, Liver Transplantation

Professor of Medicine and Surgery

Emory Healthcare Network Physician
Gastroenterology (Board certified since 1993)
Transplant Hepatology (Board certified since 2006)
Internal Medicine (Board certified since 1983)
Areas of Clinical Interest:
biliary disease
biliary tumors
liver cancer
liver disease
liver transplant evaluation
liver tumor
portal hypertension
variceal bleeding
Office(s) Locations:
Emory Transplant Center at ESJH
5673 Peachtree Dunwoody Rd #350
Atlanta, GA 30342
855 366-7989
About Dr. Spivey

Dr. Spivey is Professor of Medicine and Surgery, and most recently appointed as Vice Chair for Clinical Affairs for the Department of Medicine. Due to his new appointment, Dr. Spivey has stepped down from his role as Medical Director of Liver Transplantation and Director of Hepatology where he served for the past 10 years. Dr. Spivey joined Emory in 2005 after 12 years in the Mayo Clinic system where he was the founding Medical Director of the liver transplant program at the Mayo Clinic Jacksonville. Since joining Emory, he has worked primarily to build a hepatology and liver transplant program that would serve first the state of Georgia and the southeast region of the country. Dr. Spivey earned a Certificate of Added Qualification in Transplant Hepatology in 2006.

Year Started Practicing: 1983
Year Started Practicing at Emory: 2005
Organizational Memberships:
American Association for the Study of Liver Diseases
American Gastroenterological Association
American Society of Transplantation
Major or Recent Publications:

Teperman LW, Poordad F, Bzowej N, Martin P, Pungpapong S, Schiano T, Flaherty J, Dinh P, Rossi S, Subramanian GM and Spivey J. Trial of emtricitabine/tenofovir disoproxil fumarate after hepatitis B immunoglobulin withdrawal after liver transplantation. Liver Transplantation 2013 June;19:594-601

H. J. Prajapati, J. R. Spivey, S. I. Hanish, B. F. El-Rayes, J. S. Kauh, Z. Chen & H. S. Kim. mRECIST and EASL responses at early time point by contrast-enhanced dynamic MRI predict survival in patients with unresectable hepatocellular carcinoma (HCC) treated by doxorubicin drug-eluting beads transarterial chemoembolization (DEB TACE). Annals of Oncology, 2013 Apr;24(4):965-73

Badell IR, Hanish SI, Hughes CB, Hewitt WR, Chung RT, Spivey JR, Knechtle SJ. Domino Liver Transplantation in Maple Syrup Urine Disease: A Case Report and Review of the Literature. Transplant Proc. 2013 Mar;45(2):806-9

Gonzales P, Dhanasekaran R, West J, Subramanian R, Parekh S, Spivey JR, Reshamwala P, Martin LG, Kim HS. Influence of transjugular intrahepatic portosystemic shunt in patients awaiting orthotopic liver transplant on post-transplant outcome. Gastrointestinal Intervention, December 2012, Vol. 1, No. 1: 69-73.

Capuron L, Pagnoni G, Drake DF, Woolwine BJ, Spivey JR, Crowe RJ, Votaw JR, Goodman MM, Miller AH. Dopaminergic mechanisms of reduced basal ganglia responses to hedonic reward during interferon alfa administration. Arch Gen Psychiatry. 2012 Oct;69(10):1044-53

1983: House Officer Teaching Award
Bowman Gray School of Medicine

1983: Osler Award, Department of Medicine
Bowman Gray School of Medicine, Outstanding Resident in Internal Medicine

1990: Outstanding Medical Fellow Award
Jackson Memorial Hospital, University of Miami

2007 : Attending of the Year, Division of Gastroenterology
Presented by the Gastroenterology Fellows

2008: Golden Apple Award for excellence in teaching at Emory University Hospital
Presented by the Internal Medicine Residents

2009 : Fellow, Woodruff Leadership Academy
Emory University

2011: Golden Apple Award for excellence in teaching at Emory University Hospital
Presented by the Internal Medicine Residents

2014 : Nanette Wenger Service Award, Associate Professor
Medical School
Tulane University School of Medicine, New Orleans

North Carolina Baptist Hospital, Winston-Salem, NC

University of Miami School of Medicine, Miami, FL

Mayo Clinic, Rochester, MN